Elysian Life Sciences Private Limited, a struck off private limited company, was established on 02 March 2010 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232KA2010PTC052742. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹11.22 Cr and a paid-up capital of ₹11.22 Cr.
It upholds a compliant status. Its leadership includes Sharat Pandu Rang Narasapur (Director), Tushar Pravinchandra Mistry (Director). Past directors included Parag Surendrabhai Shah, Shridhara Kela, Sharat Pandu Rang Narasapur. Its latest AGM occurred on 25 August 2020, with the balance sheet filed on 31 March 2020. It is based at Star Ii, Opp. Iim, Bilekahalli, Bannerghatta Road,, Bangalore, Karnataka, 560076.
U24232KA2010PTC052742
052742
02 March 2010
₹11.22 Cr
₹11.22 Cr
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Elysian Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharat Pandu Rang Narasapur | Director | 10 May 2017 | Current |
| Tushar Pravinchandra Mistry | Director | 10 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2011 | Past |
| Pramod Abcsdd | Director | 10 May 2017 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2017 | Past |
| Pramod Abcsdd | Director | 10 May 2017 | Past |
| Pramod Abcsdd | Director | 01 Dec 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elysian Life Sciences Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.62% increase in profit. The company's net worth dipped by a decrease of 0.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Elysian Life Sciences had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Elysian Life Sciences has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elysian Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elysian Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Elysian Life Sciences Private Limited last Annual general meeting of members was held on 25 Aug 2020 as per latest MCA records. was completed.
Progress on Elysian Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore. was documented.
The activity Sharat Pandu Rang Narasapur was appointed as a Director was appointed as a Director on 10 May 2017 & has been associated with this company since 8 years 7 months . was completed.
Tushar Pravinchandra Mistry was appointed as a Director was appointed as a Director on 10 May 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
Elysian Life Sciences Private Limited was registered on 02 Mar 2010 with Roc Bangalore & aged 15 years 9 months as per MCA records. was recorded as a recent event.
The animal healthcare company also looks to tap into multibillion dollar foreign markets to expand its growth potential..
The CIN of Elysian Life Sciences Private Limited is U24232KA2010PTC052742.
Elysian Life Sciences Private Limited is headquartered at Star Ii, Opp. Iim, Bilekahalli, Bannerghatta Road,, Bangalore, Karnataka, 560076.
Elysian Life Sciences Private Limited was incorporated on 02 March 2010.
The current directors of Elysian Life Sciences Private Limited are
The primary industry of Elysian Life Sciences Private Limited is Pharma.
Elysian Life Sciences Private Limited is unlisted.
The authorized capital of Elysian Life Sciences Private Limited is ₹11.22 Cr, and the paid-up capital is ₹11.22 Cr.
The compliance status of Elysian Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX